Stewart D - Search Results

1

Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy.

Liu J, Stewart D, Fontaine A, Peters A, Fleury I, Mollica L, Prica A, Buckstein R, Sehn L, Jiang A, Kuruvilla J, Villa D. Liu J, et al. Among authors: stewart d. Leuk Lymphoma. 2020 Oct;61(10):2492-2496. doi: 10.1080/10428194.2020.1772472. Epub 2020 Jun 10. Leuk Lymphoma. 2020. PMID: 32519592 No abstract available.

2

Successful treatment of posttransplant lymphoproliferative disorder in a renal transplant patient by autologous peripheral blood stem cell transplantation.

Bobey NA, Stewart DA, Woodman RC. Bobey NA, et al. Leuk Lymphoma. 2002 Dec;43(12):2421-3. doi: 10.1080/1042819021000040170. Leuk Lymphoma. 2002. PMID: 12613536

3

pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.

Stewart DA, Bahlis N, Mansoor A. Stewart DA, et al. Leuk Lymphoma. 2009 Aug;50(8):1276-82. doi: 10.1080/10428190903015628. Leuk Lymphoma. 2009. PMID: 19562614

4

Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.

Peters AC, Duan Q, Russell JA, Duggan P, Owen C, Stewart DA. Peters AC, et al. Leuk Lymphoma. 2011 Nov;52(11):2124-9. doi: 10.3109/10428194.2011.594925. Epub 2011 Jul 8. Leuk Lymphoma. 2011. PMID: 21740097

5

A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.

Stewart DA, Duan Q, Carlson L, Russell JA, Bahlis NJ, Duggan P, Hasegawa W, Voralia M. Stewart DA, et al. Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):475-82. doi: 10.1016/j.clml.2011.06.012. Epub 2011 Aug 10. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21831743 Clinical Trial.

6

Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma.

Shafey M, Duan Q, Russell J, Duggan P, Balogh A, Stewart DA. Shafey M, et al. Leuk Lymphoma. 2012 Apr;53(4):596-602. doi: 10.3109/10428194.2011.624227. Leuk Lymphoma. 2012. PMID: 21929284

7

Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience.

Alimohamed N, Daly A, Owen C, Duggan P, Stewart DA. Alimohamed N, et al. Leuk Lymphoma. 2012 May;53(5):862-7. doi: 10.3109/10428194.2011.633250. Epub 2011 Dec 6. Leuk Lymphoma. 2012. PMID: 22023529 Clinical Trial.

8

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies.

Sehn LH, Assouline SE, Stewart DA, Mangel J, Gascoyne RD, Fine G, Frances-Lasserre S, Carlile DJ, Crump M. Sehn LH, et al. Among authors: stewart da. Blood. 2012 May 31;119(22):5118-25. doi: 10.1182/blood-2012-02-408773. Epub 2012 Mar 20. Blood. 2012. PMID: 22438256 Free article. Clinical Trial.

9

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA, MacDonald DA, Buckstein R, Lee C, Alzahrani M, Rubinger M, Foley R, Xenocostas A, Sabloff M, Muccilli A, Chua N, Couture F, Larouche JF, Cohen S, Connors JM, Ambler K, Al-Tourah A, Ramadan KM, Kuruvilla J. Villa D, et al. Among authors: stewart da. J Clin Oncol. 2013 Mar 20;31(9):1164-71. doi: 10.1200/JCO.2012.44.0693. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401459

10

High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma.

Vijay A, Duan Q, Henning JW, Duggan P, Daly A, Shafey M, Bahlis NJ, Stewart DA. Vijay A, et al. Leuk Lymphoma. 2013 Dec;54(12):2620-6. doi: 10.3109/10428194.2013.783211. Epub 2013 Apr 16. Leuk Lymphoma. 2013. PMID: 23472969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,701 results

Search Page

Filters